July 5, 2019
Cyxone asks Polich CEC to start second phase testing of its candidate Rabeximod in RA
Swedish Cyxone has submitted an application to the CEC in Poland for permission to start a clinical phase IIb trial with Cyxone’s drug candidate Rabeximod in RA , marking the first regulatory step towards the initiation of the study.